Most not too long ago, it's been identified that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to some big range of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and doesn't activate a 2nd